Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangzhou Finance Holdings Group is a prominent state-owned financial holding company established by the Guangzhou Municipal Government to drive regional industrial development. The group serves as a critical engine for the life sciences sector in Southern China, managing specialized vehicles such as the Guangzhou Biopharmaceutical and Health Industry Investment Fund. Through its healthcare investment arm, the group provides capital, strategic guidance, and infrastructure support to biotechnology, pharmaceutical, and medical device companies. It plays a pivotal role in the development of the Guangzhou International Bio-Island and other high-tech industrial parks, fostering an ecosystem for medical innovation within the Guangdong-Hong Kong-Macao Greater Bay Area. Its portfolio includes significant investments in major pharmaceutical groups and emerging biotech startups focused on oncology, metabolic diseases, and advanced medical technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guangzhou Finance Holdings Group.